
Dr D'Amato on the Implications of Data With Olaparib Plus Temozolomide in Advanced Uterine Leomyosarcoma
"[Although] the study didn’t meet its end point, it doesn't mean the combination isn't effective. It's just might not be better than what we have. However, I would still say that it's a potential treatment option." Gina Z. D’Amato …